Mechanisms of Topoisomerase I Inhibition by Anticancer Drugs
- 1 January 1994
- book chapter
- research article
- Published by Elsevier BV in Advances in Pharmacology
- Vol. 29, 73-92
- https://doi.org/10.1016/s1054-3589(08)61132-1
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cellsEuropean Journal Of Cancer, 1992
- Regulation of the function of eukaryotic DNA topoisomerase I: analysis of the binding step and of the catalytic constants of topoisomerization as a function of DNA topologyBiochemistry, 1990
- Protein kinase C phosphorylates DNA topoisomerase IFEBS Letters, 1989
- ADP-ribosylation of ADPR-transferase and topoisomerase I in intact mouse epidermal cells JB6Biochemistry, 1989
- Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavageJournal of Molecular Biology, 1988
- Breakage of single-stranded DNA by eukaryotic type 1 topoisomerase occurs only at regions with the potential for base-pairingJournal of Molecular Biology, 1984
- Virus- and cell-encoded tyrosine protein kinases inactivate DNA topoisomerases in vitroNature, 1984
- Phosphorylation of purified Novikoff hepatoma topoisomerase IBiochemical and Biophysical Research Communications, 1983
- Mechanism of the reaction catalyzed by the DNA untwisting enzyme: Attachment of the enzyme to 3′-terminus of the nicked DNAJournal of Molecular Biology, 1978
- Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecinBiochemical and Biophysical Research Communications, 1971